Indeed, DCAF7 knockdown significantly enhanced sorafenib sensitivity and dramatically suppressed Huh7 xenograft tumor growth in vivo, without altering the mouse body weight (Fig. 7C–F and Fig. S7A). Here, DCAF7 is linked to neoplasm.